News-Medical.Net November 4, 2024
Updated Alzheimer’s guidelines aim to reduce misdiagnoses by focusing on at-risk individuals, helping clinicians and patients make informed decisions about cognitive health and preventive care.
In a recent study published in JAMA Neurology, researchers from the International Working Group (IWG) reviewed the literature and proposed updated diagnostic criteria for Alzheimer’s disease (AD). They concluded that individuals who are cognitively normal but positive for AD biomarkers should not be diagnosed with AD but rather classified as “at risk” to avoid potentially distressing or unnecessary labeling and to focus on those at a higher likelihood of developing symptoms.
Background
The Alzheimer’s Association’s (AA) updated criteria suggest defining AD based solely on the presence of specific biological markers, allowing for an AD diagnosis...
Today's Sponsors
Today's Sponsor